GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Compass Pathways PLC (FRA:5Y6) » Definitions » Other Operating Expense

Compass Pathways (FRA:5Y6) Other Operating Expense : €-11.89 Mil (TTM As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Compass Pathways Other Operating Expense?

Compass Pathways's Other Operating Expense for the three months ended in Jun. 2024 was €-3.45 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 was €-11.89 Mil.

Compass Pathways's quarterly Other Operating Expense increased from Dec. 2023 (€-3.08 Mil) to Mar. 2024 (€-2.85 Mil) but then declined from Mar. 2024 (€-2.85 Mil) to Jun. 2024 (€-3.45 Mil).

Compass Pathways's annual Other Operating Expense declined from Dec. 2021 (€-8.54 Mil) to Dec. 2022 (€-13.62 Mil) but then increased from Dec. 2022 (€-13.62 Mil) to Dec. 2023 (€-11.81 Mil).


Compass Pathways Other Operating Expense Historical Data

The historical data trend for Compass Pathways's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Compass Pathways Other Operating Expense Chart

Compass Pathways Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial -2.46 -3.49 -8.54 -13.62 -11.81

Compass Pathways Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.33 -2.52 -3.08 -2.85 -3.45

Compass Pathways Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-11.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Compass Pathways Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Compass Pathways's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Compass Pathways Business Description

Traded in Other Exchanges
Address
33 Broadwick Street, London, GBR, W1F 0DQ
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

Compass Pathways Headlines

No Headlines